12th Annual Meeting DIA Japan 2015

With the establishment of AMED, R&D budgets in the medical sector which various ministries and agencies have possessed separately until now, were integrated into one. It therefore became possible to manage research consistently, from the basic research stage to practical application. As a result, information on drug discovery seeds, which is found at universities and government research institutions in Japan, will be sorted out and organized, and development of drugs at the early stages is anticipated to move forward, all at once. In his lecture, Dr. Suematsu will be asked to describe AMED’s organization, projects and research areas, and discuss his views on the cooperative setup between patients and industry-government-academia which the AMED should aim at, going forward.